Clinical Trial Update: Neoadjuvant FDC With Melatonin or Metformin for Locally Advanced Breast Cancer. [Phase 2]

View source ↗

Summary

Phase 2 Neoadjuvant trial evaluating a fixed-dose combination with melatonin or metformin for locally advanced breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• FDC with Melatonin
• metformin (metformin)

Snippet

Sponsor: N.N. Petrov National Medical Research Center of Oncology | Conditions: Breast Cancer | Phase 2 | Status: UNKNOWN